Hypoxic, glycolytic metabolism is a vulnerability of B-acute lymphoblastic leukemia-initiating cells.
Hypoxic, glycolytic metabolism is a vulnerability of B-acute lymphoblastic leukemia-initiating cells.
复制标题
DOI:
10.1016/j.celrep.2022.110752
复制
发表时间:
2022-04-26
期刊:
影响因子:
8.8
通讯作者:
Rowe, R. Grant
中科院分区:
文献类型:
--
作者:
Morris, Vivian;Wang, Dahai;Li, Zhiheng;Marion, William;Hughes, Travis;Sousa, Patricia;Harada, Taku;Sui, Shannan Ho;Naumenko, Sergey;Kalfon, Jeremie;Sensharma, Prerana;Falchetti, Marcelo;da Silva, Renan Vinicius;Candelli, Tito;Schneider, Pauline;Margaritis, Thanasis;Holstege, Frank C. P.;Pikman, Yana;Harris, Marian;Stam, Ronald W.;Orkin, Stuart H.;Koehler, Angela N.;Shalek, Alex K.;North, Trista E.;Pimkin, Maxim;Daley, George Q.;da Rocha, Edroaldo Lummertz;Rowe, R. Grant
High-risk forms of B-acute lymphoblastic leukemia (B-ALL) remain a therapeutic challenge. Leukemia-initiating cells (LICs) self-renew and spark relapse and therefore have been the subject of intensive investigation; however, the properties of LICs in high-risk B-ALL are not well understood. Here, we use single-cell transcriptomics and quantitative xenotransplantation to understand LICs in MLL-rearranged (MLL-r) B-ALL. Compared with reported LIC frequencies in acute myeloid leukemia (AML), engraftable LICs in MLL-r B-ALL are abundant. Although we find that multipotent, self-renewing LICs are enriched among phenotypically undifferentiated B-ALL cells, LICs with the capacity to replenish the leukemic cellular diversity can emerge from more mature fractions. While inhibiting oxidative phosphorylation blunts blast proliferation, this intervention promotes LIC emergence. Conversely, inhibiting hypoxia and glycolysis impairs MLL-r B-ALL LICs, providing a therapeutic benefit in xenotransplantation systems. These findings provide insight into the aggressive nature of MLL-r B-ALL and provide a rationale for therapeutic targeting of hypoxia and glycolysis. Morris et al. use single-cell transcriptomics to identify a candidate-initiating cell in B-acute lymphoblastic leukemia (B-ALL) with rearrangement of the KMT2A/MLL1 locus (MLL-r), finding that this population is plastic and exists in a hypoxic state that can be pharmacologically targeted.
登录
查看更多内容
影响因子:
30.8
作者:
Andersson AK;Ma J;Wang J;Chen X;Gedman AL;Dang J;Nakitandwe J;Holmfeldt L;Parker M;Easton J;Huether R;Kriwacki R;Rusch M;Wu G;Li Y;Mulder H;Raimondi S;Pounds S;Kang G;Shi L;Becksfort J;Gupta P;Payne-Turner D;Vadodaria B;Boggs K;Yergeau D;Manne J;Song G;Edmonson M;Nagahawatte P;Wei L;Cheng C;Pei D;Sutton R;Venn NC;Chetcuti A;Rush A;Catchpoole D;Heldrup J;Fioretos T;Lu C;Ding L;Pui CH;Shurtleff S;Mullighan CG;Mardis ER;Wilson RK;Gruber TA;Zhang J;Downing JR;St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project
通讯作者:
St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project
影响因子:
28.2
作者:
Hayashi Y;Zhang Y;Yokota A;Yan X;Liu J;Choi K;Li B;Sashida G;Peng Y;Xu Z;Huang R;Zhang L;Freudiger GM;Wang J;Dong Y;Zhou Y;Wang J;Wu L;Bu J;Chen A;Zhao X;Sun X;Chetal K;Olsson A;Watanabe M;Romick-Rosendale LE;Harada H;Shih LY;Tse W;Bridges JP;Caligiuri MA;Huang T;Zheng Y;Witte DP;Wang QF;Qu CK;Salomonis N;Grimes HL;Nimer SD;Xiao Z;Huang G
通讯作者:
Huang G
影响因子:
50.3
作者:
Chapuy B;McKeown MR;Lin CY;Monti S;Roemer MG;Qi J;Rahl PB;Sun HH;Yeda KT;Doench JG;Reichert E;Kung AL;Rodig SJ;Young RA;Shipp MA;Bradner JE
通讯作者:
Bradner JE
影响因子:
64.5
作者:
Delmore JE;Issa GC;Lemieux ME;Rahl PB;Shi J;Jacobs HM;Kastritis E;Gilpatrick T;Paranal RM;Qi J;Chesi M;Schinzel AC;McKeown MR;Heffernan TP;Vakoc CR;Bergsagel PL;Ghobrial IM;Richardson PG;Young RA;Hahn WC;Anderson KC;Kung AL;Bradner JE;Mitsiades CS
通讯作者:
Mitsiades CS
影响因子:
23.9
作者:
Fumagalli, Arianna;Oost, Koen C.;van Rheenen, Jacco
通讯作者:
van Rheenen, Jacco